UBS, Retires

UBS Retires Credit Suisse Debt as Executives Cash Out Ahead of Bern's Capital Verdict

Published on 09/02/2026 at 17:21 | Editorial boerse-global.de

UBS tenders up to $6B for Credit Suisse bonds, cutting costs, while Swiss capital debate and insider sales weigh on shares.

SMI-Börsentafel mit Kurscharts und Händlern auf blau beleuchtetem Trading-Floor
UBS Group AG CH0244767585 auf Börsen-Editorial-Bild mit SMI-Kurstafel und Trading-Floor-Atmosphäre in Zürich Illustration mit AI erstellt.

The machinery of the Credit Suisse integration grinds on even as a separate, more political battle over UBS's future capital requirements reaches its decisive phase. In a move that went largely unnoticed at the Swiss bourse, the bank has launched tender offers for nine bonds originally issued by its fallen rival, a step designed to streamline its funding structure and trim interest costs.

The buyback covers instruments maturing between 2028 and 2033, carrying coupons ranging from 0.50 percent to 4.375 percent. Across the nine tranches, UBS has put up to roughly $6 billion on the table, split across dollars, euros and sterling. The offer is structured in "Any and All" and "Maximum Purchase" formats, with 9.54 billion dollars, 2.05 billion euros and 1.2 billion pounds in scope. Investors have until September 10 to tender, with settlement slated for September 14.

The debt retirement is paired with fresh issuance: UBS has simultaneously placed new senior holdco bonds in pounds and euros, replacing more expensive Credit Suisse paper with funding priced on its own terms. Management frames the exercise as active management of its funding and TLAC structure — a technical but strategically significant step in shedding the legacy of the 2023 emergency takeover.

The Capital Question Hangs Overhead

None of this happens in a political vacuum. The buyback lands as Swiss lawmakers and the government remain at loggerheads over how much capital UBS should hold. The bank has quantified the potential additional burden from the so-called WAK-S motion at $13 billion in extra AT1 capital, plus another $2 billion in CET1 stemming from proposed ordinance changes. Since the Credit Suisse acquisition, UBS says it has already built $15 billion in additional CET1 — putting roughly $30 billion in extra Tier-1 capital potentially in play.

CEO Sergio Ermotti has said he is examining alternatives to the Federal Council's proposals. A parliamentary committee recently softened its stance, demanding $16 billion in AT1 capital rather than the government's original, stricter requirements — and no additional CET1 at all. The finance minister has pushed back against this parliamentary compromise, insisting on full CET1 funding for foreign subsidiaries where parliament would allow AT1 to cover half. The dispute involves around $20 billion and is likely to keep weighing on the share price in the weeks ahead.

Should investors sell immediately? Or is it worth buying UBS?

Insider Sales Cluster Around the Verdict

Against that backdrop, a flurry of insider selling has caught attention. Over roughly three and a half weeks, more than 137,000 UBS shares changed hands among executives and board members at prices between 43.17 and 43.98 francs — a period when the stock was trading near its yearly high.

The transactions broke down as follows: on August 10, an executive board member sold 80,000 shares at 43.33 francs, worth around 3.47 million francs. On August 25, a non-executive board member offloaded 7,500 shares at 43.17 francs. The following day, another executive member sold 50,000 shares at 43.98 francs, netting roughly 2.2 million francs.

For the year to date, insider sales total 28 million francs, with August alone accounting for 7.7 million francs. Such filings rarely carry definitive signals — executives sell for liquidity planning and portfolio diversification, particularly when the stock has run up. But the timing is notable: the sales clustered in the weeks immediately preceding the parliamentary committee's decision on capital requirements, a topic that has shadowed the stock for months.

Solid Fundamentals Beneath the Noise

The selling context is a bank in good operational shape. In late July, UBS reported second-quarter 2026 pretax profit of $3.6 billion and net income of $2.8 billion, with a return on hard core capital of 15.4 percent. Core business segments lifted underlying pretax profit by 47 percent year on year. Wealth management attracted $73 billion in net new money during the first half, including $36 billion in the second quarter alone. The bank also announced a share buyback of up to $3 billion by mid-2027.

These figures help explain why the stock has held up through the summer's political uncertainty. They also frame the insider sales: taking profits at elevated valuations while regulatory questions remain unresolved is not necessarily a bearish signal.

Market Reaction Stays Measured

The stock dipped 2.4 percent on the day the parliamentary committee adopted its compromise proposal, closing at 46.79 euros — a move read as profit-taking after the market had priced in an even softer outcome. At the German trading venue, UBS shares recently changed hands at 47.46 euros, up 1.4 percent, leaving the stock 1.5 percent below its 52-week high of 48.19 euros and roughly 20 percent above its 200-day average. The 50-day average of 45.77 euros sits below the current level, pointing to an intact short-term uptrend.

The bond buyback itself triggered barely a ripple in Zurich, where the shares hovered around 44 francs. For investors, the tender offer remains a technical but meaningful piece of the puzzle: UBS is steadily dismantling the Credit Suisse inheritance and repositioning its own funding architecture — all while the political fight over its future capital buffer plays out in the background. A final law is not expected before late 2026, leaving ample room for the debate to shape the stock's trajectory through the autumn parliamentary session.

Ad

UBS Stock: New Analysis - 2 September

Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated UBS analysis...

Disclaimer...

en | CH0244767585 | UBS | boerse | 70044685 |